In crisis?
HCA’s lobby is temporarily closed for walk-in customer service. Learn about customer service options.
Meetings and materials
The P&T Committee / DUR Board meet at least quarterly. All meetings are open to the public.
On this page
Meetings and materials: Pharmacy and Therapeutic (P&T) Committee/Drug Utilization Review (DUR) Board
Upcoming meetings
All 2022 P&T Committee meetings with be held by webinar until further notice.
August 17, 2022
October 19, 2022
December 14, 2022
Materials
Drug class reports will be taken down 30 days after the meeting.
| Date | General documents | P&T Documents | DUR documents |
|---|---|---|---|
|
June 15, 2022 WEBINAR ONLY |
|
Second generation antipsychotics in children report TIMs for plaque psoriasis and psoriatic arthritis report TIMs for rheumatoid arthritis and ankylosing spondylitis report |
|
|
April 20, 2022 MEETING CANCELED |
|||
|
February 16, 2022 WEBINAR ONLY |
Biologics for non-asthma motion Postponed: second generation antipsychotics in children |
Postponed: endocrine and metabolic agents |
Meeting details
- All P&T Committee/DUR Board meetings are open to the public.
- Stakeholders will be allowed three minutes for comments.
- Written testimony: If you would like to give testimony, but cannot attend a meeting, please email a two-page maximum letter to the WPDP program at least one week before the meeting. She will put your testimony in the P&T Committee binders. If your testimony is longer than two pages, contact Leta for an address to mail it to. If you provide new drug information that has not been reviewed by the Drug Effectiveness Review Project (DERP), it cannot be considered by the committee.
- Committee discussion and motions follow stakeholder comments.
- If you have questions about the Apple Health PDL, please email the Apple Health pharmacy policy team.
- Meetings are sponsored by the Health Care Authority and meet requirements of the Americans with Disabilities Act. Please call our ADA Coordinator at 360-725-9976 to make a request for special accommodations. TRS users may call this number through the Washington Relay Service by dialing 711.
Meetings held by webinar
If you would like to speak on any topic listed on the agenda, email the WPDP program, by the Monday before the meeting date:
- Your name;
- The organization you represent; and
- The drug class name on the agenda.
The Committee Chair will call these names after the drug class presentation. You will be unmuted and have 3 minutes to speak. If you do not sign up ahead of time, but would like to speak at the meeting, the Committee Chair will ask if there are any other stakeholders. "Raise your hand", you will be unmuted when your name is called. You will have 3 minutes to speak. You can also ask questions in the "chat" box.
Meetings held at the Conference Center
- Directions to The Conference Center in Sea-Tac airport.
- Sign up at the meeting to testify on a drug class. Stakeholder sign-up sheets are located in the lobby.
Medicaid supplemental rebates
Effective January 1, 2018 HCA joined The Optimal PDL Solution (TOP$) supplemental rebate pool administered by Provider Synergies, a subsidiary of Magellan Medicaid Administration, LLC.
Please refer to the TOP$ website for more information about contracting and submitting rebates.
For additional Medicaid questions, please send an email to Apple Health (Medicaid).
Request archived materials
Email: PDP@hca.wa.gov
Stakeholder list
If you would like to receive P&T/DUR meeting agendas and drug class updates sign up for the Prescription Drug Program Stakeholder List.